安徽医药
安徽醫藥
안휘의약
ANHUI MEDICAL AND PHARMACEUTICAL JOURNAL
2015年
9期
1726-1729
,共4页
肾癌%CT%MRI%出血
腎癌%CT%MRI%齣血
신암%CT%MRI%출혈
kidney carcinoma%CT%MRI%hemorrhage
目的:探究磁共振成像技术( MRI)与CT扫描检查辅助判断肾癌内出血的准确率与可行性。方法回顾性分析2005年9月—2013年1月垫江县中医院泌尿外科收治的89例肾癌患者的临床资料。术前51例患者行螺旋CT扫描检查,38例行MRI检查,以手术切除标本的病理检查结果作为诊断的金标准。结果 CT与MRI扫描检出肿瘤内出血灶的灵敏度分别为37.7%、97.1%,特异度分别为66.7%、33.3%。相关样本t检验结果显示,MRI扫描检出肾癌内出血病灶阳性率明显高于CT扫描(t=8.12,P=0.004)。结论 MRI扫描检出肾癌内出血阳性率灵敏度较高,可以作为临床医师术前判断患者预后的另一个主要手段。
目的:探究磁共振成像技術( MRI)與CT掃描檢查輔助判斷腎癌內齣血的準確率與可行性。方法迴顧性分析2005年9月—2013年1月墊江縣中醫院泌尿外科收治的89例腎癌患者的臨床資料。術前51例患者行螺鏇CT掃描檢查,38例行MRI檢查,以手術切除標本的病理檢查結果作為診斷的金標準。結果 CT與MRI掃描檢齣腫瘤內齣血竈的靈敏度分彆為37.7%、97.1%,特異度分彆為66.7%、33.3%。相關樣本t檢驗結果顯示,MRI掃描檢齣腎癌內齣血病竈暘性率明顯高于CT掃描(t=8.12,P=0.004)。結論 MRI掃描檢齣腎癌內齣血暘性率靈敏度較高,可以作為臨床醫師術前判斷患者預後的另一箇主要手段。
목적:탐구자공진성상기술( MRI)여CT소묘검사보조판단신암내출혈적준학솔여가행성。방법회고성분석2005년9월—2013년1월점강현중의원비뇨외과수치적89례신암환자적림상자료。술전51례환자행라선CT소묘검사,38례행MRI검사,이수술절제표본적병리검사결과작위진단적금표준。결과 CT여MRI소묘검출종류내출혈조적령민도분별위37.7%、97.1%,특이도분별위66.7%、33.3%。상관양본t검험결과현시,MRI소묘검출신암내출혈병조양성솔명현고우CT소묘(t=8.12,P=0.004)。결론 MRI소묘검출신암내출혈양성솔령민도교고,가이작위림상의사술전판단환자예후적령일개주요수단。
Objective To evaluate the accuracy and feasibility of CT and MRI scanning on determination of hemorrhage in kidney carci-nomas.Methods A retrospective review on the clinical data of 89 patients who were admitted to hospital for renal cell carcinomas and received treatment during September 2005 to January 2013.51 patients underwent CT scanning,and 38 cases underwent MRI scanning. Results of histopathological test were considered as the golden standard.Results The sensitivities of CT and MRI scanning in detecting hemorrhage in renal cell carcinomas were 37.7%and 97.1%,respectively; and specificities were 66.7% and 33.3%,respectively. Results of the correlated samples t test showed that MRI scanning had a significantly higher positive rate in evaluating hemorrhage of re-nal cell carcinomas than CT examinations.Conclusion MRI is one of the means to detect hemorrhagic lesions in patients with kidney cancer,which is helpful for evaluating its prognosis.